Inactief instrument

Andere talen Ambrx Biopharma Inc.

Aandelen

Ambrx Biopharma Inc. Announces Resignation of Andrew Aromando as Chief Operating Officer	12/03
Johnson & Johnson Completes Ambrx Acquisition	07/03
J&J : finalise l'acquisition d'Ambrx Biopharma pour 2 Mds$	07/03
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from NASDAQ Composite Index	07/03
Johnson & Johnson completed the acquisition of Ambrx Biopharma Inc. from a group of shareholders.	07/03
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from S&P Global BMI Index	07/03
Ambrx Biopharma Shareholders Approve Johnson & Johnson Acquisition Deal	06/03
Ambrx Shareholders Approve Acquisition by Johnson & Johnson	06/03
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from NASDAQ Biotechnology Index	06/03
J&J's Acquisition of Ambrx Biopharma Completes Hart-Scott-Rodino Waiting Period	22/02
Le bric-à-brac de Zonebourse : Trois records historiques, une galaxie lointaine et du M&A	06/02
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update	23/01
North American Morning Briefing : Central Bankers -2-	17/01
North American Morning Briefing : Focus Fixed on -2-	11/01
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	09/01
Tiens, revoilà Nvidia	09/01
En Direct des Marchés : Airbus, Sanofi, Dassault Aviation, Trigano, Samsung, Novartis, GSK...	09/01
EN DIRECTO DESDE LOS MERCADOS: Grifols, Airbus, Boeing, Sony, Shell, Nike, Brunello Cucinelli, Samsung, J&J, GSK...	09/01
Bolsa de Madrid: ¡Nvidia ha vuelto!	09/01
Health Care Up as Merger Wave Continues -- Health Care Roundup	09/01

Geen resultaten voor deze zoekopdracht